cas 2034424-04-7|| where to buy 4-{2-[(benzyloxy)methyl]pyrrolidin-1-yl}-1-(2-phenyl-2H-1,2,3-triazole-4-carbonyl)piperidine

Product Name:4-{2-[(benzyloxy)methyl]pyrrolidin-1-yl}-1-(2-phenyl-2H-1,2,3-triazole-4-carbonyl)piperidine

IUPAC Name:4-{2-[(benzyloxy)methyl]pyrrolidin-1-yl}-1-(2-phenyl-2H-1,2,3-triazole-4-carbonyl)piperidine

Packing Unit	Available Stock	Price($)	Quantity

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2034424-04-7 regularly via the above email.

Additional Notes

Verification code*

refresh

: CAS NO:2034424-04-7; Molecular Formula:C26H31N5O2; Melting Point:-; Smiles Code:O=C(N1CCC(CC1)N1CCCC1COCC1=CC=CC=C1)C1=NN(N=C1)C1=CC=CC=C1; Density:

: Catalog Number:CM883715; Molecular Weight:445.57; Boiling Point:; MDL No:; Storage:

: Piperidines; Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.; Piperidine,Piperidine Price; if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.

: Pyrrolidines; Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.

: Triazoles; Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.